Combination of stromal-derived factor-1α and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization

Journal of Vascular Surgery

Volumn 50, Issue 3, 2009, Pages 608-616

  Yu, Jian Xing ^a   Huang, Xue Fei ^a   Lv, Wei Ming ^a   Ye, Cai Sheng ^a   Peng, Xin Zhi ^a   Zhang, Hui ^a   Xiao, Long Bin ^b   Wang, Shen Ming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b First Affiliated Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; LIPOCORTIN 5; RETROVIRUS VECTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOWMETRY; BONE MARROW CELL; BONE MARROW DERIVED ENDOTHELIAL PROGENITOR CELL; CAPILLARY DENSITY; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; HUMAN CELL; IN VIVO STUDY; LEG ISCHEMIA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; COMBINED MODALITY THERAPY; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE THERAPY; GENETIC VECTORS; HINDLIMB; HUMANS; INJECTIONS, INTRAMUSCULAR; ISCHEMIA; LASER-DOPPLER FLOWMETRY; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MUSCLE, SKELETAL; NEOVASCULARIZATION, PHYSIOLOGIC; REGIONAL BLOOD FLOW; RETROVIRIDAE; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSDUCTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68849128804     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2009.05.049     Document Type: Article

References (18)

1. De Falco E., Porcelli D., Torella A.R., Straino S., Iachininoto M.G., Orlandi A., et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104 (2004) 3472-3482
2. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109 (2004) 1615-1622
3. van Weel V., Seghers L., de Vries M.R., Kuiper E.J., Schlingemann R.O., Bajema I.M., et al. Expression of vascular endothelial growth factor, stromal cell-derived factor-1, and CXCR4 in human limb muscle with acute and chronic ischemia. Arterioscler Thromb Vasc Biol 27 (2007) 1426-1432
4. Salcedo R., Wasserman K., Young H.A., Grimm M.C., Howard O.M., Anver M.R., et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154 (1999) 1125-1135
5. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
6. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
7. Jin D.K., Shido K., Kopp H.G., Petit I., Shmelkov S.V., Young L.M., et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 12 (2006) 557-567
8. Kawamoto A., Gwon H.C., Iwaguro H., Yamaguchi J.I., Uchida S., Masuda H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
9. Oh I.Y., Yoon C.H., Hur J., Kim J.H., Kim T.Y., Lee C.S., et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood 110 (2007) 3891-3899
10. Broxmeyer H.E., Kohli L., Kim C.H., Lee Y., Mantel C., Cooper S., et al. Stromal cell-derived factor-1/CXCL12 directly enhances survival/antiapoptosis of myeloid progenitor cells through CXCR4 and G(alpha)i proteins and enhances engraftment of competitive, repopulating stem cells. J Leukoc Biol 73 (2003) 630-638
11. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
12. Ruiz de Almodovar C., Luttun A., and Carmeliet P. An SDF-1 trap for myeloid cells stimulates angiogenesis. Cell 124 (2006) 18-21
13. Kryczek I., Lange A., Mottram P., Alvarez X., Cheng P., Hogan M., et al. CXCL 12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65 (2005) 465-472
14. Rajagopalan S., Mohler III E.R., Lederman R.J., Mendelsohn F.O., Saucedo J.F., Goldman C.K., et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108 (2003) 1933-1938
15. Kusumanto Y.H., van Weel V., Mulder N.H., Smit A.J., van den Dungen J.J., Hooymans J.M., et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. Hum Gene Ther 17 (2006) 683-691
16. Hiasa K., Ishibashi M., Ohtani K., Inoue S., Zhao Q., Kitamoto S., et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 109 (2004) 2454-2461
17. Iwaguro H., Yamaguchi J., Kalka C., Murasawa S., Masuda H., Hayashi S., et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105 (2002) 732-738
18. Wragg A., Mellad J.A., Beltran L.E., Konoplyannikov M., San H., Boozer S., et al. VEGRF1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism. J Mol Med 86 (2008) 1221-1232